AzTrials
AzTrials

Acute Kidney InjuryNavigateAKINCT02114138

Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury

An observational study of Acute Kidney Injury, run by University of Florida at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The risk for postoperative acute kidney injury (pAKI), as for any other postoperative complications (PC), comes from a number of interactions between a patient's health before surgery, strength to tolerate surgery and influences on the operating room environment. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Acute Kidney Injury
What is being tested?
pathogenesis of perioperative acute kidney injury and urine collection
Type of treatment
Surgery or procedure
How many people
94 participants
Where
1 siteUnited States
Study dates
Jul 2015to 1 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The population from which the cohort will be selected among patients undergoing major in-hospital surgery. Healthy Adult Volunteers who meet our enrollment criteria.

Who may be able to join

  • Patients undergoing major in-hospital surgery
  • Planned hospital stay of at least 24 hours
  • Able to enroll prior to undergoing surgery
  • > 18 years old that elect to serve as a control group

Who cannot join

  • Patients not recruited 4 hours prior to undergoing surgery
  • Renal Replacement Therapy AKI/CKD Nephrectomy Organ transplant
  • Any of the following within the last 12 months:
  • Stroke/Transient Ischemic Attack
  • Heart Attack
  • Major Thoracic, abdominal, or Vascular surgery
Show all 10Show fewer
  • Radiation Therapy
  • Chemo Therapy
  • Immunosuppressive Therapy
  • IV contrast within the past 72 hours

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UF Health

    Gainesville, Florida, 32610

Other trials in United States

About this study

Official title: Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury Subtitle: Urinary Molecular and Metabolic Signature of Postoperative Acute Kidney Injury (NavigateAKI)

The risk for postoperative acute kidney injury (pAKI), as for any other postoperative complications (PC), comes from a number of interactions between a patient's health before surgery, strength to tolerate surgery and influences on the operating room environment. At this time doctors do not have good tools to predict which patients may be at risk of having this complication. The purpose of this research study is to develop a urine test that can be used to predict the risk for having problems with kidney function after major surgery.

Read the detailed description

During hospitalization, a urine sample will be collected and additional tests will be added to the daily standard of care blood samples before, during and three times following an elective surgical procedure.

Study participants will complete telephone interviews at 6 and 12 months after discharge from the hospital with a study team member. The telephone interview will consist of a short questionnaire asking about state of health and a health survey.

At the same times of the phone interviews, the study team will mail a urine dipstick that is used to detect any amount of protein in the urine. Study participants will be asked to urinate on dipstick and send it back to the study team in provided shipping material.

Healthy Controls will be enrolled to establish baseline values for kidney health based upon a single urine collection and a brief health questionnaire.

Being tested
pathogenesis of perioperative acute kidney injury, urine collection
Keywords
postoperative acute kidney injury, pAKI, stress injury on the kidney, chronic kidney disease, CKD
Medical subject headings
Acute Kidney Injury, Renal Insufficiency, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pathogenesis of perioperative acute kidney injuryProcedure or surgery

    understand pathogenesis of perioperative acute kidney injury in elective and emergent surgery

  • urine collectionDiagnostic test

    urine collection will be performed on both the control group and hospitalized participants

Study groups in NCT02114138
Study groupRoleWhat they receive
Surgical GroupAdults undergoing major in hospital surgery; pathogenesis of perioperative acute kidney injury; urine collection
Receives: Procedure: pathogenesis of perioperative acute kidney injury; Diagnostic Test: urine collection
Healthy ControlHealthy Adult volunteers who are willing to provide a 200 ml urine sample.
Receives: Diagnostic Test: urine collection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Occurrence of postoperative acute kidney injury (pAKI)

    PostoperativeAKI is a change outcome of an increase of greater than or equal to 50% of creatinine from initial level prior to surgery until postoperative day 7.

    Measured: up to 7 days after surgery.

Secondary outcomes (2)
  1. Change from baseline in urine protein biomarkers at 4 hours after surgery

    Change in urine protein biomarkers (urine insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2)) from prior to surgery (baseline) to four hours after surgery.

    Measured: Baseline, 4 hours after surgery

  2. Change from baseline in urine protein biomarkers at postoperative day 1

    Change in urine protein biomarkers (urine insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2)) from prior to surgery (baseline) to postoperative day 1

    Measured: Baseline, day 1 after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2014 (estimated)
  2. Study startJul 2015
  3. Primary completion1 Dec 2025
  4. Study completion1 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
94 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02114138
Sponsor's protocol ID
IRB201400127
Acronym
NavigateAKI
Status last verified
Jun 2025
First submitted
24 Mar 2014
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Kidney Injury, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Occurrence of postoperative acute kidney injury (pAKI) (time frame: up to 7 days after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in